Silvercrest Asset Management Group LLC Trans Medics Group, Inc. Transaction History

Silvercrest Asset Management Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$53.63 - $82.33 $876,153 - $1.35 Million	-16,337 Reduced 18.41%	72,405 $5.48 Million
Q4 2022 Feb 14, 2023	SELL	$39.08 - $64.29 $1.82 Million - $2.99 Million	-46,551 Reduced 34.41%	88,742 $5.48 Million
Q3 2022 Nov 14, 2022	SELL	$31.56 - $55.75 $115,698 - $204,379	-3,666 Reduced 2.64%	135,293 $5.65 Million
Q2 2022 Aug 15, 2022	SELL	$20.56 - $32.15 $2.67 Million - $4.17 Million	-129,794 Reduced 48.29%	138,959 $4.37 Million
Q1 2022 May 16, 2022	BUY	$12.58 - $26.94 $31,726 - $67,942	2,522 Added 0.95%	268,753 $7.24 Million
Q4 2021 Feb 14, 2022	BUY	$19.16 - $32.68 $1.16 Million - $1.98 Million	60,507 Added 29.41%	266,231 $5.1 Million
Q3 2021 Nov 15, 2021	BUY	$25.92 - $34.51 $5.33 Million - $7.1 Million	205,724 New	205,724 $6.81 Million

358

29.6M

399K

154K

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $5B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

Get notified when there are updates to the investment portfolio of Silvercrest Asset Management Group LLC, based on Form 13F filings with the SEC.

Stay updated on Silvercrest Asset Management Group LLC with notifications on news.